Literature DB >> 3891125

Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein.

H Nolly, A G Scicli, G Scicli, O A Carretero.   

Abstract

A kininogenase resembling glandular kallikrein was partially purified from vascular tissue and characterized. Saline-perfused rat tail arteries and veins were homogenized in 0.25 M sucrose containing 10 mM Tris-HCl (pH 7.4). The homogenate was centrifuged at 105,000 g for 60 minutes, and a vascular kininogenase was purified from the supernatant by chromatofocusing, affinity chromatography on immobilized antibodies against rat urinary kallikrein, and gel filtration on Sephadex G-100. The inhibitory effects of antibodies against rat urinary kallikrein were tested with equivalent kinin-forming concentrations of rat urinary kallikrein and vascular kininogenase. Kininogenase activities of both enzymes were similarly inhibited by both polyclonal and monoclonal antibodies. Aprotinin (1,000 KIU) completely inhibited vascular kininogenase activity, while soybean trypsin inhibitor (100 micrograms) did not modify its kinin-forming activity. Vascular kininogenase and rat urinary kallikrein had the same elution volume when chromatographed on a Sephadex G-100 column, and had similar mobilities in 10% polyacrylamide gel electrophoresis. Kinins released by vascular kininogenase were identified as bradykinin by reverse-phase high performance liquid chromatography. Rat vascular kininogenase appears to be similar to glandular kallikrein. Kinins released locally by vascular kininogenase may contribute to the regulation of vascular tone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891125     DOI: 10.1161/01.res.56.6.816

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  Vascular remodeling and the kallikrein-kinin system.

Authors:  Oscar A Carretero
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Characterization of Gaddum's substance R.

Authors:  G J Douglas; K I Williams; R J Flower
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 3.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

4.  Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.

Authors:  L M Chen; L Chao; R K Mayfield; J Chao
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 6.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Respective roles of kallikrein and endopeptidase 24.11 in the metabolic pathway of atrial natriuretic peptide in the rat.

Authors:  Y Vanneste; S Pauwels; L Lambotte; A Michel; R Dimaline; M Deschodt-Lanckman
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

8.  Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.

Authors:  B S Dixon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.

Authors:  N B Oza; J H Schwartz; H D Goud; N G Levinsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 10.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.